Squitieri F - Search Results

1

Aripiprazole in the treatment of Huntington's disease: a case series.

Ciammola A, Sassone J, Colciago C, Mencacci NE, Poletti B, Ciarmiello A, Squitieri F, Silani V. Ciammola A, et al. Among authors: squitieri f. Neuropsychiatr Dis Treat. 2009;5:1-4. Epub 2009 Apr 8. Neuropsychiatr Dis Treat. 2009. PMID: 19557093 Free PMC article.

2

Italian Huntington disease patients--data and tissue bank.

Squitieri F, Cannella M, Gaudio L, Martino T, Maglione V, Giallonardo P, Simonelli M, Simonelli G, Mangeruga D, Ciarmiello A, Pierelli F. Squitieri F, et al. Neurol Sci. 2003 Oct;24(3):215-6. doi: 10.1007/s10072-003-0137-8. Neurol Sci. 2003. PMID: 14598094

3

Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?

Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O. Squitieri F, et al. Mech Ageing Dev. 2006 Feb;127(2):208-12. doi: 10.1016/j.mad.2005.09.012. Epub 2005 Nov 7. Mech Ageing Dev. 2006. PMID: 16274727 Review.

4

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F. Ciarmiello A, et al. Among authors: squitieri f. J Nucl Med. 2006 Feb;47(2):215-22. J Nucl Med. 2006. PMID: 16455626 Free article. Clinical Trial.

5

The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction.

Squitieri F, Ciarmiello A, Di Donato S, Frati L. Squitieri F, et al. Eur J Neurol. 2006 Apr;13(4):408-15. doi: 10.1111/j.1468-1331.2006.01264.x. Eur J Neurol. 2006. PMID: 16643321 Review.

6

Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects.

Ciammola A, Sassone J, Alberti L, Meola G, Mancinelli E, Russo MA, Squitieri F, Silani V. Ciammola A, et al. Among authors: squitieri f. Cell Death Differ. 2006 Dec;13(12):2068-78. doi: 10.1038/sj.cdd.4401967. Epub 2006 May 26. Cell Death Differ. 2006. PMID: 16729030

7

Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V. Ciammola A, et al. Among authors: squitieri f. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):574-7. doi: 10.1002/ajmg.b.30501. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17427191

8

Neuroprotective effects of riluzole in Huntington's disease.

Squitieri F, Ciammola A, Colonnese C, Ciarmiello A. Squitieri F, et al. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):221-2. doi: 10.1007/s00259-007-0615-y. Epub 2007 Nov 6. Eur J Nucl Med Mol Imaging. 2008. PMID: 17987289 No abstract available.

9

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.

Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A. Squitieri F, et al. CNS Neurosci Ther. 2009 Winter;15(1):1-11. doi: 10.1111/j.1755-5949.2008.00068.x. CNS Neurosci Ther. 2009. PMID: 19228174 Free PMC article.

10

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Squitieri F, Orobello S, Cannella M, Martino T, Romanelli P, Giovacchini G, Frati L, Mansi L, Ciarmiello A. Squitieri F, et al. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1113-20. doi: 10.1007/s00259-009-1103-3. Epub 2009 Mar 11. Eur J Nucl Med Mol Imaging. 2009. PMID: 19280185 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters